About Pridus Global Pharma
Pridus Global Pharma is a company based in Bengaluru (India) founded in 2022. It operates as a B2B. Pridus Global Pharma offers products and services including Life Science Research, Cell Culture & Regenerative Medicine, Diagnostics Kits & Assay Development, Drug Discovery & Metabolic Research, and Immunology Research. Pridus Global Pharma operates in a competitive market with competitors including WuXi AppTec, Eurofins Scientific, Ipsen, ANI Pharmaceuticals and Red Nucleus, among others.
- Headquarter Bengaluru, India
- Employees 1
- SectorsHealthcare
- Email••••••••
- Website pridusglobalpharma.com
- Legal Name Pridus Global Pharma Private Limited
- Date of Incorporation 22 Sep, 2022
- Jurisdiction Bangalore, Karnataka, India
- Annual Revenue₹1.56 Cr
FY 2024 · +420% YoY
- Net Loss-₹73,460
FY 2024 · 0% margin
- EBITDA-₹37,460
FY 2024 · 0% margin
- Employee Count1
Associated legal entities of Pridus Global Pharma
Pridus Global Pharma operates through Pridus Global Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Pridus Global Pharma Private Limited CIN U24299KA2022PTC166363 | Active | 22 Sep 2022 | Bangalore, Karnataka | ₹1.6 Cr | – | 2 | View details |
Products & Services of Pridus Global Pharma
Pridus Global Pharma offers a comprehensive portfolio of products and services, including Life Science Research, Cell Culture & Regenerative Medicine, Diagnostics Kits & Assay Development, Drug Discovery & Metabolic Research, and Immunology Research.
Solutions for advancing life science and biological research.
Products supporting cell culture and regenerative medicine applications.
Kits and assays for developing diagnostic tests and research.
Tools for drug discovery and metabolic studies in science.
Resources for immunology and related scientific investigations.
Board of directors of Pridus Global Pharma Private Limited (Pridus Global Pharma)
Pridus Global Pharma Private Limited is the primary company behind Pridus Global Pharma. The board of Pridus Global Pharma Private Limited currently have 2 directors; the longest-serving is Usha Choudhary, appointed in 2022. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Usha Choudhary DIN 09745353 | Director | 22 Sep 2022 | 4 yrs | Pridus Global Pharma Private Limited |
| Ishwar Chouhdary DIN 10068813 | Director | 13 Mar 2023 | 3 yrs 6 mo | Pridus Global Pharma Private Limited |
Financials of Pridus Global Pharma
Figures of Pridus Global Pharma Private Limited, the primary company behind Pridus Global Pharma, for FY 2024. Revenue was ₹1.56 Cr (+420% year on year). Net loss was -₹73,460 (0% margin). EBITDA was -₹37,460 (0% margin).
- ₹1.56 CrRevenue · FY 2024 · +420% YoY
- -₹73,460Net loss · 0% margin
- -₹37,460EBITDA · 0% margin
- ₹1 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Pridus Global Pharma Private Limited are on its company page.
Detailed financial statements for Pridus Global Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Pridus Global Pharma
Pridus Global Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as WuXi AppTec, Eurofins Scientific, Ipsen, ANI Pharmaceuticals and Red Nucleus, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| wuxiapptec.com | 2000 | Shanghai, China | $40M | 1,681 | Provider of CRO and CDMO services | |
| eurofins.com | 1987 | Luxembourg | – | – | Laboratory testing and contract research services are provided globally. | |
| ipsen.com | 1929 | – | – | 505 | Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes | |
| anipharmaceuticals.com | 1996 | Baudette, United States | – | 600 | Branded and generic prescription drugs are developed, manufactured, and marketed. | |
| rednucleus.com | 2014 | Yardley, United States | – | 176 | Advisory, scientific, and medical communications provided for pharmaceutical industry. | |
| aptar.com | 1992 | Crystal Lake, United States | – | 232 | Regulatory support, brand differentiation, and prototyping services are provided. | |
| cheplapharm.com | 1998 | Mesekenhagen, Germany | – | 840 | Branded pharmaceutical products are developed, marketed, and distributed globally. | |
| aliadatx.com | 2021 | Boston, United States | $33M | – | Provider of drug research & development services for multiple therapeutic areas | |
| cms.net.cn | 1992 | Shenzhen, China | – | – | Generic formulations including tablets, capsules, liquids, and injectables are manufactured. |
Detailed competitors of Pridus Global Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Pridus Global Pharma
10 companies that operate in the same segment as Pridus Global Pharma (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Pridus Global Pharma
Pridus Global Pharma was founded in 2022.
Pridus Global Pharma is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Pridus Global Pharma has 1 employees.
The primary company behind Pridus Global Pharma, Pridus Global Pharma Private Limited, reported revenue of ₹1.56 Cr for FY 2024, up 420% year on year.
Pridus Global Pharma delivers comprehensive solutions for various research areas including life science, cell culture, regenerative medicine, diagnostics kits, assay development, drug discovery, metabolic research, immunology, molecular biology, protein research, cancer research, and biosimilar vaccine development. They focus on driving research through high-quality products and services. Based in India, they serve institutions and professionals in these fields with reliable end-to-end support.
Pridus Global Pharma's top competitors include WuXi AppTec, ANI Pharmaceuticals and Aptar.
Pridus Global Pharma offers Life Science Research, Cell Culture & Regenerative Medicine, Diagnostics Kits & Assay Development, Drug Discovery & Metabolic Research, and Immunology Research.
Pridus Global Pharma operates through Pridus Global Pharma Private Limited.
The legal entities of Pridus Global Pharma currently have 2 directors, including Usha Choudhary, Ishwar Chouhdary.